Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin

Growth Hormone and IGF Research

Volumn 21, Issue 3, 2011, Pages 134-139

  Vindeløv, Signe Diness ^a   Hartoft Nielsen, Marie Louise ^a   Rasmussen, Åse Krogh ^a   Bendtzen, Klaus ^a   Kosteljanetz, Michael ^a   Andersson, Anna Maria ^a   Feldt Rasmussen, Ulla ^a  

^a Rigshospitalet   (Denmark)

Author keywords

GH; IL 1 ; IL 6; IL 8; Pituitary cells (human somatotroph adenoma cells)

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SOMATOSTATIN;

ACROMEGALY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ADENOMA; ADULT; FEMALE; GROWTH HORMONE-RELEASING HORMONE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HORMONES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; PITUITARY GLAND; SOMATOSTATIN;

EID: 79958117184     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.03.005     Document Type: Article

References (70)

1. Central Brain Tumor Registry of The United States. 2010. Ref Type: Report.
2. Molitch M.E. Pituitary tumours: pituitary incidentalomas. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:667-675.
3. Arzt E., Pereda M.P., Castro C.P., Pagotto U., Renner U., Stalla G.K. Pathophysiological role of the cytokine network in the anterior pituitary gland. Front. Neuroendocrinol. 1999, 20:71-95.
4. Borg S.A., Kerry K.E., Royds J.A., Battersby R.D., Jones T.H. Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells. Eur. J. Endocrinol. 2005, 152:293-300.
5. Jones T.H., Justice S., Price A., Chapman K. Interleukin-6 secreting human pituitary adenomas in vitro. J. Clin. Endocrinol. Metab. 1991, 73:207-209.
6. Jones T.H., Kennedy R.L., Justice S.K., Price A. Interleukin-1 stimulates the release of interleukin-6 from cultured human pituitary adenoma cells. Acta Endocrinol. (Copenh) 1993, 128:405-410.
7. Jones T.H., Daniels M., James R.A., Justice S.K., McCorkle R., Price A., Kendall-Taylor P., Weetman A.P. Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J. Clin. Endocrinol. Metab. 1994, 78:180-187.
8. Green V.L., Atkin S.L., Speirs V., Jeffreys R.V., Landolt A.M., Mathew B., Hipkin L., White M.C. Cytokine expression in human anterior pituitary adenomas. Clin. Endocrinol. (Oxf) 1996, 45:179-185.
9. Suliman M.E., Royds J.A., Baxter L., Timperley W.R., Cullen D.R., Jones T.H. IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas. Eur. J. Endocrinol. 1999, 140:155-158.
10. Thiele J.O., Lohrer P., Schaaf L., Feirer M., Stummer W., Losa M., Lange M., Tichomirowa M., Arzt E., Stalla G.K., Renner U. Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas. Eur. J. Endocrinol. 2003, 149:455-461.
11. Tichomirowa M., Theodoropoulou M., Lohrer P., Schaaf L., Losa M., Uhl E., Lange M., Arzt E., Stalla G.K., Renner U. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4. J. Neuroendocrinol. 2005, 17:152-160.
12. Ueta Y., Levy A., Chowdrey H.S., Lightman S.L. S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas. J. Neuroendocrinol. 1995, 7:467-474.
13. Velkeniers B., Vergani P., Trouillas J., D'Haens J., Hooghe R.J., Hooghe-Peters E.L. Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J. Histochem. Cytochem. 1994, 42:67-76.
14. Renner U., Gloddek J., Pereda M.P., Arzt E., Stalla G.K. Regulation and role of intrapituitary IL-6 production by folliculostellate cells. Domest. Anim. Endocrinol. 1998, 15:353-362.
15. Todd V.L., Atkin S.L., Speirs V., White M.C. PCR expression of cytokines in anterior pituitary adenomas. J. Endocrinol. 2010, 144(Suppl):285.
16. Schneider J.H., Hofman F.M., Weiss M.H., Hinton D.R. Cytokine expression in pituitary adenomas. Program of the 3rd International Pituitary Congres. MP10 1993, Ref Type: Conference Proceeding.
17. Stepien H., Zerek-Melen G., Mucha S., Winczyk K., Fryczak J. Interleukin-1 beta stimulates cell proliferation in the intermediate lobe of the rat pituitary gland. J. Endocrinol. 1994, 140:337-341.
18. Arzt E., Buric R., Stelzer G., Stalla J., Sauer J., Renner U., Stalla G.K. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 1993, 132:459-467.
19. Graciarena M., Carbia-Nagashima A., Onofri C., Perez-Castro C., Giacomini D., Renner U., Stalla G.K., Arzt E. Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model. Eur. J. Endocrinol. 2004, 151:595-604.
20. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
21. Taylor P.C., Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 2009, 5:578-582.
22. Rasmussen A.K., Diamant M., Blichert-Toft M., Bendtzen K., Feldt-Rasmussen U. The effects of interleukin-1beta (IL-1beta) on human thyrocyte functions are counteracted by the IL-1 receptor antagonist. Endocrinology 1997, 138:2043-2048.
23. Eizirik D.L., Strandell E., Bendtzen K., Sandler S. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1. Diabetes 1988, 37:916-919.
24. Dinarello C.A. Biology of interleukin 1. FASEB J. 1988, 2:108-115.
25. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 1994, 179:53-56. 26-9.
26. Katsuura G., Arimura A., Koves K., Gottschall P.E. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am. J. Physiol. 1990, 258:E163-E171.
27. Morales-Montor J., Mohamed F., Baghdadi A., Baig S., Hallal-Calleros C., Damian R.T. Expression of mRNA for interleukin-1beta, interleukin-6, tumor necrosis factor-alpha and macrophage migration inhibitory factor in HPA-axis tissues in Schistosoma mansoni-infected baboons (Papio cynocephalus). Int. J. Parasitol. 2003, 33:1515-1524.
28. Koenig J.I., Snow K., Clark B.D., Toni R., Cannon J.G., Shaw A.R., Dinarello C.A., Reichlin S., Lee S.L., Lechan R.M. Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology 1990, 126:3053-3058.
29. Lang C.H., Pollard V., Fan J., Traber L.D., Traber D.L., Frost R.A., Gelato M.C., Prough D.S. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am. J. Physiol. 1997, 273:R371-R378.
30. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 1991, 77:1627-1652. 15-4.
31. Peisen J.N., McDonnell K.J., Mulroney S.E., Lumpkin M.D. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and corticotropin-releasing factor in the juvenile rat. Endocrinology 1995, 136:3378-3390.
32. French R.A., Zachary J.F., Dantzer R., Frawley L.S., Chizzonite R., Parnet P., Kelley K.W. Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology 1996, 137:4027-4036.
33. Sauer J., Renner U., Hopfner U., Lange M., Muller A., Strasburger C.J., Pagotto U., Arzt E., Stalla G.K. Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures. J. Clin. Endocrinol. Metab. 1998, 83:2429-2434.
34. Ueland T., Fougner S.L., Godang K., Lekva T., Schurgers L.J., Scholz H., Halvorsen B., Schreiner T., Aukrust P., Bollerslev J. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly. J. Clin. Endocrinol. Metab. 2010, 95:361-368.
35. Kurotani R., Yasuda M., Oyama K., Egashira N., Sugaya M., Teramoto A., Osamura R.Y. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Mod. Pathol. 2001, 14:791-797.
36. Spangelo B.L., Judd A.M., Isakson P.C., MacLeod R.M. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989, 125:575-577.
37. Spangelo B.L., Judd A.M., Isakson P.C., MacLeod R.M. Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology 1991, 128:2685-2692.
38. Thorn A., Tuxen M., Moesby L., Hansen E.W., Christensen J.D. Regulation of interleukin-6 secretion in murine pituicytes. Eur. J. Pharmacol. 2005, 519:168-174. 5-9.
39. Yamaguchi M., Matsuzaki N., Hirota K., Miyake A., Tanizawa O. Interleukin 6 possibly induced by interleukin 1 beta in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinol. (Copenh) 1990, 122:201-205.
40. Diamant M., Kayser L., Rasmussen A.K., Bech K., Feldt-Rassmussen U. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1. Autoimmunity 1991, 11:21-26.
41. Siejka A., Stepien T., Lawnicka H., Krupinski R., Komorowski J., Stepien H. Effect of the growth hormone-releasing hormone [GHRH(1-44)NH2] on IL-6 and IL-8 secretion from human peripheral blood mononuclear cells in vitro. Endocr. Regul. 2005, 39:7-11.
42. Andoh A., Hata K., Shimada M., Fujino S., Tasaki K., Bamba S., Araki Y., Fujiyama Y., Bamba T. Inhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Int. J. Mol. Med. 2002, 10:89-93.
43. Grimaldi M., Florio T., Schettini G. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase. Biochem. Biophys. Res. Commun. 1997, 235:242-248. 9-6.
44. Spangelo B.L., Horrell S., Goodwin A.L., Shroff S., Jarvis W.D. Somatostatin and gamma-aminobutyric acid inhibit interleukin-1 beta-stimulated release of interleukin-6 from rat C6 glioma cells. Neuroimmunomodulation 2004, 11:332-340.
45. Lang A., Sakhnini E., Fidder H.H., Maor Y., Bar-Meir S., Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int. 2005, 25:808-816.
46. Matsushima K., Baldwin E.T., Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol. 1992, 51:236-265.
47. Weetman A.P., Bennett G.L., Wong W.L. Thyroid follicular cells produce interleukin-8. J. Clin. Endocrinol. Metab. 1992, 75:328-330.
48. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. U.S.A. 1993, 90:10193-10197. 1-11.
49. Komorowski J., Jankiewicz-Wika J., Stepien H. Somatostatin (SOM) and octreotide (OCT) inhibit the secretion of interleukin-8 (IL-8) from human peripheral blood mononuclear cells (PBMC) in vitro. Horm. Metab. Res. 2000, 32:337-338.
50. Peluso G., Petillo O., Melone M.A., Mazzarella G., Ranieri M., Tajana G.F. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides 1996, 30:443-451.
51. Oosterom R., Blaauw G., Singh R., Verleun T., Lamberts S.W. Isolation of large numbers of dispersed human pituitary adenoma cells obtained by aspiration. J. Endocrinol. Invest. 1984, 7:307-311.
52. Snyder J., Hymer W.C., Wilfinger W.W. Culture of human pituitary prolactin and growth hormone cells. Cell Tissue Res. 1978, 191:379-388. 16-8.
53. Frawley L.S., Neill J.D. A reverse hemolytic plaque assay for microscopic visualization of growth hormone release from individual cells: evidence for somatotrope heterogeneity. Neuroendocrinology 1984, 39:484-487.
54. Rasmussen A.K., Kayser L., Perrild H., Brandt M., Bech K., Feldt-Rasmussen U. Human thyroid epithelial cells cultured in monolayers. I. Decreased thyroglobulin and cAMP response to TSH in 12-week-old secondary and tertiary cultures. Mol. Cell. Endocrinol. 1996, 116:165-172. 5-2.
55. Haedo M.R., Gerez J., Fuertes M., Giacomini D., Paez-Pereda M., Labeur M., Renner U., Stalla G.K., Arzt E. Regulation of pituitary function by cytokines. Horm. Res. 2009, 72:266-274.
56. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van D.R., Desmet C.J., Aarden L.A., Mooi W.J., Peeper D.S. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031. 13-6.
57. Arzt E., Chesnokova V., Stalla G.K., Melmed S. Pituitary adenoma growth: a model for cellular senescence and cytokine action. Cell Cycle 2009, 8:677-678. 1-3.
58. Harada A., Mukaida N., Matsushima K. Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases. Mol. Med. Today 1996, 2:482-489.
59. Sawada T., Koike K., Kanda Y., Sakamoto Y., Nohara A., Ohmichi M., Hirota K., Miyake A. In vitro effects of CINC/gro, a member of the interleukin-8 family, on hormone secretion by rat anterior pituitary cells. Biochem. Biophys. Res. Commun. 1994, 202:155-160. 15-7.
60. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987, 238:519-521. 23-10.
61. Beach J.E., Smallridge R.C., Kinzer C.A., Bernton E.W., Holaday J.W., Fein H.G. Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci. 1989, 44:1-7.
62. Niimi M., Sato M., Wada Y., Tamaki M., Takahara J., Kawanishi K. Analysis of growth hormone release from rat anterior pituitary cells by reverse hemolytic plaque assay: influence of interleukin-1. Life Sci. 1994, 55:1807-1813.
63. Gong F.Y., Deng J.Y., Shi Y.F. Stimulatory effect of interleukin-1beta on growth hormone gene expression and growth hormone release from rat GH3 cells. Neuroendocrinology 2005, 81:217-228.
64. Fry C., Gunter D.R., McMahon C.D., Steele B., Sartin J.L. Cytokine-mediated growth hormone release from cultured ovine pituitary cells. Neuroendocrinology 1998, 68:192-200.
65. Mainardi G.L., Saleri R., Tamanini C., Baratta M. Effects of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, alone or in association with hexarelin or galanin, on growth hormone gene expression and growth hormone release from pig pituitary cells. Horm. Res. 2002, 58:180-186.
66. Renner U., Newton C.J., Pagotto U., Sauer J., Arzt E., Stalla G.K. Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology 1995, 136:3186-3193.
67. Uehara A., Gillis S., Arimura A. Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinology 1987, 45:343-347.
68. Gong F.Y., Shi Y.F., Deng J.Y. The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells. J. Endocrinol. 2006, 190:397-406.
69. Gong F.Y., Deng J.Y., Shi Y.F. Mek and p38 MAPK-dependant pathways are involved in the positive effect of interleukin-6 on human growth hormone gene expression in rat MtT/S somatotroph cells. Chin. Med. Sci. J. 2008, 23:73-80.
70. Lyson K., McCann S.M. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991, 54:262-266.